EGC CEO, Dr. Eva Garland, moderated a panel titled “Executing My Award” at the SBIR/STTR Spring Innovation Conference.
Accelerating development of innovative technologies
EGC’s extraordinary team of scientists and accountants are ready to secure and manage non-dilutive funding to support your scientific innovations. Contact us to learn more.
Related Posts
February 27, 2026
Attending ARPA-H BIOGAMI Proposers’ Day: What Actually Matters
By broadening the set of agencies, programs, and partnerships you consider, you can diversify funding sources, reduce vulnerability to individual…
February 3, 2026
February 2026 Newsletter
This month, EGC highlights our client Kernal Biologics and their $48M ARPA-H award advancing next-generation cell therapies, shares a 2026 compliance…
January 29, 2026
A New Year Checklist: Key Compliance and Tax Deadlines for 2026
Here are some key dates to keep in mind for organizations with a December 31st fiscal year-end. Early planning for these deadlines can help avoid…
January 15, 2026
1300+ Small Business Leaders Sign Letter to Congress
Over 1,300 CEOs and innovation leaders representing all 50 states, Washington, DC, and Puerto Rico are calling for immediate Congressional action to…